TRex Bio, Inc.

expected

Oct 9, 2026

per news reports

status

Filed with SEC

The expected listing date (Oct 9, 2026) comes from news reporting, not a regulatory filing — regulators publish a filing or approval date, not the day a company starts trading. See the source. It is replaced automatically if an official date is published.

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

United States

Incorporated in

Overview

— AI-generated from the filing, see note below

Business overview

TRex Bio, Inc. focuses on collaborations and partnerships in the biotech industry, generating revenue primarily through collaborative agreements.

Revenue model

The company's revenue model includes generating collaboration revenue, which was reported at $39,108 for the year ended December 31, 2024, and no revenue for subsequent years leading to June 30, 2026.

Risk factors

Investing in common stock involves high risks.
Additional risks and uncertainties not currently known may adversely affect business.
This offering may not be successful due to unforeseen challenges.

Use of proceeds

Not disclosed in the provided filing text.

This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.

IPO details

The expected date is Oct 9, 2026. TRex Bio, Inc. is headquartered in United States and incorporated in DE. It is classified under Biological Products, (No Diagnostic Substances).

Related IPO lists

Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with TRex Bio, Inc..

Biotech IPOs United States IPOs

Embed this company

Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.

Iframe — WordPress / Ghost / Notion / Webflow

<iframe src="https://www.discoveripo.com/embed/trex-bio" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="TRex Bio, Inc. — DiscoverIPO"></iframe>

Dark by default. For a light background, use https://www.discoveripo.com/embed/trex-bio?theme=light as the src instead.

Share image — Substack, email, anywhere

https://www.discoveripo.com/ipo/trex-bio/opengraph-image

Attribution text

TRex Bio, Inc. IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/trex-bio?utm_source=embed&utm_medium=text&utm_campaign=trex-bio

Track this IPO

Get emailed when TRex Bio, Inc.'s terms, price, or expected date change — no weekly noise, just this company.

Frequently asked questions

When is TRex Bio, Inc. expected to go public?

TRex Bio, Inc. is expected to list on Oct 9, 2026.

Where this data comes from

Registration statement filed with the U.S. Securities and Exchange Commission. Retrieved Oct 5, 2026.

View the original filing on SEC EDGAR →

Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.